AYV Acma
- 0.022
- 0.0000.00%
Acma News
Acma Granted More Time to Hold 2023 Shareholder Meeting
Acma (SGX:AYV) received approval from the Singapore Exchange to hold its annual general meeting on June 18 for the financial period ended Dec. 31, 2023, according to a Singapore bourse filing on Frida
Xsolis Returns as Platinum Sponsor of ACMA National Conference, Showcases Human-Centered AI Solutions
ACMA features professionals affiliated with case management and transitions of care and will take place in Nashville on April 19th-22nd NASHVILLE, Tenn., April 16, 2024 /PRNewswire/ -- Xsolis, a lead
ACMA Extends Deadline of Proposed Sale of Subsidiary
ACMA (SGX:AYV) agreed to extend the completion of the proposed sale of its subsidiary Acot Tooling (Xiamen) to Fong Choi Yoke to July 26, according to a filing with the Singapore Exchange on Wednesday
ACMA Launches Pharmaceutical Industry Think Tank Series
The Accreditation Council for Medical Affairs (ACMA) Think Tank will conduct research, analyze complex issues, and provide informed policy...
Acma Swings to Loss in H2 2023 as Revenue Falls 14.5%
Acma (SGX:AYV) posted SG$2.8 million in attributable loss in the second half of 2023, versus an attributable profit of SG$159,000 in the year-ago period, according to a Friday filing. Diluted loss per
Acma to Sell Mold Manufacturing Unit in China
Acma's (SGX:AYV) wholly-owned indirect subsidiary, Global Tech, agreed to sell Acot Tooling (Xiamen), a manufacturer of molds in China, to Fong Choy Yoke for a nominal cash consideration of SG$1, acco
ACMA Introduces First Ever Accredited, Professional Certification for Specialty Pharmaceutical Sales Professionals
NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA), a globally recognized leader and the first and only accrediting body for the pharmaceutical industry, tod
BenevolentAI: Appointment Of Catherine Isted, ACMA, As Chief Financial Officer >BAI.AE
BenevolentAI: Appointment Of Catherine Isted, ACMA, As Chief Financial Officer >BAI.AE
New Web Platform Launched by the ACMA to Empower Healthcare Providers in Reporting Unethical Practices by Pharma Reps and Medical Science Liaisons
NEW YORK, April 11, 2023 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA), a globally recognized leader and the first and only accrediting body for the pharmaceutical industry ann
THE ACCREDITATION COUNCIL FOR MEDICAL AFFAIRS (ACMA) DEVELOPS FIRST EVER BOARD-CERTIFIED BIOLOGICS & BIOSIMILARS SPECIALIST (BCBBS) CERTIFICATION
NEW YORK, Dec. 6, 2022 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) is launching a new Board Certification program focused on biologics and biosimilars. This is the first and
Dr. Tania Small, Global Head of Oncology Medical Affairs and Chair of R&D Diversity, Equity, and Inclusion Council at GSK, Appointed to the Board of Governors of the Accreditation Council for Medical Affairs (ACMA)
NEW YORK--(BUSINESS WIRE)--The Accreditation Council for Medical Affairs (ACMA) announces the appointment of Tania Small, MD, Global Head of Oncology Medical Affairs and Chair of R&D Diversity, Eq
Singapore Stocks Start Week Lower; Mm2 Asia Shares Climb 2% on Bond Deal for Cinema Business
05:42 AM EDT, 09/26/2022 (MT Newswires) -- Singapore's Straits Times Index started the week in negative territory, extending last week's sell-off, amid growing fears over an economic recession. Durin
ACMA to Dispose of 100% Stake in Equipment Trading Unit
02:48 AM EDT, 09/26/2022 (MT Newswires) -- ACMA (SGX:AYV) said its unit Acma Technologies has agreed to sell a 100% stake in Hong Kong-incorporated Rinzai, together with all amounts owed by Rinzai to
ACMA To Offer Board Certification program for Biologics and Biosimilars
Board Certified Biologics & Biosimilars Specialist (BCBBS) program will launch in 2022.NEW YORK, June 28, 2022 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) announced toda
ACMA Records 3 Straight Year of Losses, to be Placed on Watch List
01:02 AM EDT, 04/14/2022 (MT Newswires) -- Plastic product manufacturer ACMA (SGX:AYV) issued a notice that it recorded three consecutive years of pre-tax losses based on its audited full-year consoli
ACMA Narrows Attributable Consolidated Net Loss in H2 2021
10:40 PM EST, 03/01/2022 (MT Newswires) -- ACMA (SGX:AYV) narrowed its consolidated attributable loss to SG$736,000 ($542,949) in the six months ended Dec. 31, 2021, as against SG$3.1 million a year a
Acma Selling 100% Stake in Vietnam-based Metal Printing, Packaging Services Company
12:52 AM EST, 12/29/2021 (MT Newswires) -- Acma's (SGX:AYV) subsidiary Xenon Manufacturing has agreed to dispose of the entire share capital of Vietnam-based metal printing and packaging services com
Press Release: Sun Life Reports Third Quarter 2021 Results
Sun Life Reports Third Quarter 2021 Results PR Newswire TORONTO, Nov. 3, 2021 Sun Life Financial Inc. ("SLF Inc."), its subsidiaries and, where applicable, its joint ventures and associate
The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare
Partnership will bring first GMP manufactured products to be sold through Valens in both Australia and New Zealand Access to Epsilon's GMP facility in Australia to provide Valens with future acces
Macmahon Target Price Raised 10% to A$0.33/Share by Macquarie>MAH.AU
*DJ Macmahon Target Price Raised 10% to A$0.33/Share by Macquarie>MAH.AU (END) Dow Jones Newswires August 25, 2021 20:22 ET (00:22 GMT) Copyright (c) 2021 Dow Jones & Company, Inc.
Analysis
Price Target
No Data
